Renaissance Technologies’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $106K | Sell |
69,442
-14,073
| -17% | -$21.5K | ﹤0.01% | 3290 |
|
2025
Q1 | $103K | Buy |
83,515
+43,465
| +109% | +$53.5K | ﹤0.01% | 3198 |
|
2024
Q4 | $125K | Buy |
40,050
+300
| +0.8% | +$933 | ﹤0.01% | 3253 |
|
2024
Q3 | $112K | Buy |
39,750
+900
| +2% | +$2.54K | ﹤0.01% | 3242 |
|
2024
Q2 | $211K | Buy |
38,850
+1,600
| +4% | +$8.69K | ﹤0.01% | 3029 |
|
2024
Q1 | $160K | Sell |
37,250
-300
| -0.8% | -$1.29K | ﹤0.01% | 3276 |
|
2023
Q4 | $207K | Sell |
37,550
-2,700
| -7% | -$14.9K | ﹤0.01% | 3122 |
|
2023
Q3 | $183K | Buy |
40,250
+8,300
| +26% | +$37.7K | ﹤0.01% | 3116 |
|
2023
Q2 | $99K | Buy |
31,950
+12,600
| +65% | +$39K | ﹤0.01% | 3476 |
|
2023
Q1 | $14K | Buy |
19,350
+3,030
| +19% | +$2.19K | ﹤0.01% | 3865 |
|
2022
Q4 | $43K | Buy |
16,320
+1,170
| +8% | +$3.08K | ﹤0.01% | 3825 |
|
2022
Q3 | $56K | Sell |
15,150
-11,620
| -43% | -$43K | ﹤0.01% | 3727 |
|
2022
Q2 | $88K | Sell |
26,770
-31,657
| -54% | -$104K | ﹤0.01% | 3879 |
|
2022
Q1 | $257K | Sell |
58,427
-48,473
| -45% | -$213K | ﹤0.01% | 3538 |
|
2021
Q4 | $1.02M | Buy |
106,900
+8,390
| +9% | +$79.7K | ﹤0.01% | 2624 |
|
2021
Q3 | $1.67M | Buy |
98,510
+58,520
| +146% | +$989K | ﹤0.01% | 2230 |
|
2021
Q2 | $1.12M | Buy |
+39,990
| New | +$1.12M | ﹤0.01% | 2617 |
|
2021
Q1 | – | Sell |
-31,836
| Closed | -$462K | – | 3566 |
|
2020
Q4 | $462K | Buy |
31,836
+9,136
| +40% | +$133K | ﹤0.01% | 2855 |
|
2020
Q3 | $341K | Sell |
22,700
-9,262
| -29% | -$139K | ﹤0.01% | 2952 |
|
2020
Q2 | $662K | Buy |
31,962
+8,492
| +36% | +$176K | ﹤0.01% | 2762 |
|
2020
Q1 | $446K | Buy |
23,470
+11,560
| +97% | +$220K | ﹤0.01% | 2814 |
|
2019
Q4 | $343K | Buy |
+11,910
| New | +$343K | ﹤0.01% | 3037 |
|